Your search returned 4 results.

Results
	1.	Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies. [electronic resource] by Goldwater, Ronald Hussaini, Azra Bosch, Bill Nemeth, Paul Producer: 20180321 In: Clinical pharmacokinetics vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. [electronic resource] by Altman, Roy Bosch, Bill Brune, Kay Patrignani, Paola Young, Clarence Producer: 20160215 In: Drugs vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate. [electronic resource] by Hussaini, Azra Olszanski, Anthony J Stein, Cy A Bosch, Bill Nemeth, Paul Producer: 20171227 In: Cancer chemotherapy and pharmacology vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study. [electronic resource] by Stein, Cy A Levin, Richard Given, Robert Higano, Celestia S Nemeth, Paul Bosch, Bill Chapas-Reed, Jillian Dreicer, Robert Producer: 20181022 In: Urologic oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)